In This Issue
Launch of National Clinical Guideline: National Early Warning Score
NMBI On-line Continuing Professional Development (CPD) Directory Frequently Asked Questions (FAQs)
Development of a Child and Family Health Needs Assessment (CFHNA)
New Forum and Recommendations for Diabetes Injection Technique
Events, Courses and Research that may be of interest to you
Useful Links
About us »
Feedback »
Visit our website »
Upcoming events »
Newsletter section »
Education courses »
Contact us »
Contact

Ph: 01 639 8500

Fax: 01 639 8595

Email: ezine@nmbi.ie

Web: www.nmbi.ie


New Forum and Recommendations for Diabetes Injection Technique

The Forum, which comprises experienced specialist diabetes nurses, is dedicated to establishing and promoting best practice in injection technique for all involved in diabetes care, and aims to raise awareness of emerging and existing research relating to injection technique and the impact this may have on health outcomes.

The Forum’s overarching vision is to help all those with diabetes using injectable therapies achieve the best possible health outcomes by ensuring that the dose is delivered to the right injection site, using the right technique, every time.


One of FIT Ireland’s first actions has been the launch of the First Irish Injection Technique Recommendations for people with diabetes who use injectable therapies, which have been adapted from the First UK Injection Technique Recommendations 2nd Edition, published by FIT UK.  The First Irish Injection Technique Recommendations can be found at: www.fit4diabetes.com/ireland .

 

The recommendations include the latest advice on injection sites and care, the correct use of pen devices, needle length, rotation of injection sites and much more.  A scale is included throughout to show the weight a recommendation should have in daily practice and the degree of support in medical literature.

 

Poor technique can lead to injectable therapies not being absorbed properly.  This, in turn, may cause immediate problems such as hypoglycaemia (a sudden drop in blood sugar because of accelerated insulin absorption) and/or hyperglycaemia (a rise in blood sugar because of slow insulin absorption).  Longer-term problems can also include lipohypertrophy (accumulation of fat under the skin caused by injecting too frequently in the same area).  Lipohypertrophy may cause variability in the absorption of insulin. 

 

The FIT Ireland founding board explain: “Injection technique is one of the keystones of diabetes injection therapy and it is vital that people get it right.  It has not always been given the recognition it truly deserves and it should be a priority in the management of injection therapies. To increase awareness of this important issue, FIT Ireland has been formed.” 

 

FIT is supported by medical technology company BD and both are committed to promoting injection technique best practice.


The Forum’s founding board is:

 

  • Helen Twamley, Clinical Nurse Manager, Beaumont Hospital – (+353 1 809 3000)
  • Sonya Browne Gleeson, Clinical Nurse Specialist, Beaumont Hospital – (+353 1 809 3000)
  • Helen Burke, Advanced Nurse Practitioner, University College Hospital Galway – (+353 091 542 222)
  • Patricia Coady, Clinical Nurse Specialist, Cork University Hospital – (+353 21 492 2896)
  • Yvonne Moloney, Clinical Midwife Specialist, Mid Western Regional Maternity Hospital – (+353 061 483 481)

 

For more information or queries regarding FIT Ireland, please contact:


Laura Blott
Lindsell Marketing

020 7402 0510

laura@lindsellmarketing.com  

 

Rate: 12345 (3) | Share
Newsletter Marketing Powered by Newsweaver